FDA Inspection
Strides Pharma Science LimitedStrides Pharma Science Limited – FDA Inspection, Feb 24, 2023
Record Details
This FDA Inspection record concerns Strides Pharma Science Limited, with an inspection on February 24, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6229cb2f-3070-400c-934a-1e4342c30548
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1198198
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
10- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.68(b)Computer control of master formula records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Strides Pharma Science Limited
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 5, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 28, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Strides Pharma Science Limited
- FDA Inspection 1078143 - 2019-02-05
- FDA Inspection 1015484 - 2017-04-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.